Survey on Oral Anti-Diabetic Drugs Available in Market for Non- Complicated Patient in Bangladesh

Abstract

Background: Based on pricing differences of the same medicine among manufacturers, this study was designed to investigate the current oral anti-diabetic medication regimens for non-complicated diabetic patients in the Mirpur region. Methods: With the help of many Mirpur medical stores, doctors, and patients, the current study was conducted over the course of 4 months with a random review of roughly 200 prescriptions. A standard questionnaire with numerous questions was developed based on patient data (such as age, gender, medical history, and prescriptions), doctor data (often prescribed drug, combination), and pharmacy data (available alternatives, cost, and most popular brands). Results: A statistical analysis of patient data suggests that 47.5% of patients are between the ages of 50 and 60 and that 92.5% of patients depend on oral anti-diabetic drugs. Their (54%) most common consequences were hypertension-related. Doctors routinely provide metformin to patients with type II diabetes mellitus, either alone or in fixed-dose combinations with glimmering or glazier, according to survey results. The cost of several different types of oral diabetes drugs varies widely, according to cost analysis (75-87%). USV Pvt. Ltd. and Mankind Ltd.'s dominance over other pharmaceutical companies may be seen in the annual revenue of these products in the regional Indian market. Conclusions: This report will create better awareness among people for the availability of various brands of same anti-diabetic drug and also motivate our physicians to prescribe the economic products. Keywords :Dhaka, Diabetes, oral antidiabetic drugs, Cost.